Table 4.
Results of radiological, bacteriological, and pathological examinations in mycobacteriosis cases.
| No | Age | Sex | Dx | Bacteriological Test | Pathological Test | Radiological Findings | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| Smear | Culture | NAAT | Path w/o AI | Path with AI | AFB Count * | |||||
| 1 | 64 | F | TB | + | + | + | + | + | 3+ | nodular shadow, consolidation, cavity |
| 2 | 57 | M | TB | − | + | + | + | + | 2+ | consolidation, LN enlargement |
| 3 | 30 | M | TB | − | − | − | − | + | 1+ | nodular shadow, consolidation |
| 4 | 80 | F | TB | − | − | − | − | + | 1+ | nodular shadow, LN enlargement |
| 5 | 78 | F | TB | − | − | − | − | + | 2+ | nodular shadow |
| 6 | 55 | M | TB | − | − | − | − | + | 1+ | nodular shadow, LN enlargement |
| 7 | 30 | M | TB | − | − | − | − | − | − | nodular shadow, bronchiectasis |
| 8 | 70 | M | NTM | + | + | + | − | + | 3+ | nodular shadow, bronchiectasis |
| 9 | 74 | F | NTM | + | + | + | − | + | 1+ | consolidation, cavity, bronchiectasis |
| 10 | 62 | F | NTM | − | − | + | − | + | 1+ | nodular shadow, bronchiectasis |
| 11 | 71 | F | NTM | + | + | + | − | − | − | nodular shadow, consolidation, bronchiectasis |
| 12 | 78 | F | NTM | − | + | + | − | − | − | nodular shadow, consolidation |
| 13 | 70 | M | NTM | − | + | + | − | − | − | nodular shadow, consolidation |
| 14 | 76 | F | NTM | − | − | + | − | − | − | nodular shadow, consolidation, cavity |
| 15 | 74 | M | f/u | − | − | − | + | 1+ | nodular shadow | |
| 16 | 71 | M | f/u | − | − | − | + | 1+ | consolidation, bronchiectasis | |
AI, artificial intelligence; COP, cryptogenic organizing pneumonia; Dx, diagnosis; f/u, follow-up; LN, lymph node; NAAT, nucleic acid amplification test; NTM, nontuberculous mycobacteriosis; Path, pathology; TB, tuberculosis; w/o, without. * (−): AFB negative, (1+): Less than 10 AFBs observed per biopsied tissue, (2+): 10–100 AFBs observed per biopsied tissue, (3+) >100 AFBs observed per biopsied tissue.